| 摘要 |
FIELD: medicine, pharmaceutics.SUBSTANCE: invention refers to chemical-pharmaceutical industry and medicine, ophthalmology, and may be used for treating corneal diseases and damages. Eye drops contain peptides associated with phospholipids, produced of cod liver, a lubricant, a buffer, a preserving agent, isotonic sodium chloride and water for injections under certain proportions. Eye drops may additionally contain an antioxidant in the amount of 0.01-0.5 wt % specified in a group consisting of sodium metabisulphite, sodium sulphite, sodium thiosulphate or trilon B provided the peptides associated with phospholipids are used in the relation of peptide and phospholipid fractions, wt %: 40-99 peptides and 1-60 phospholipids.EFFECT: drops exhibit complex anti-inflammatory, stimulating, repair processes and epithelisation.7 cl, 7 ex, 2 tbl |
